Biotron Ltd (BIT)

Sydney
0.083
+0.008(+10.67%)
  • Volume:
    4,816,865
  • Bid/Ask:
    0.083/0.084
  • Day's Range:
    0.078 - 0.086

BIT Overview

Prev. Close
0.075
Day's Range
0.078-0.086
Revenue
1.46M
Open
0.078
52 wk Range
0.046-0.115
EPS
0
Volume
4,816,865
Market Cap
58.26M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
5,254,453
P/E Ratio
-
Beta
-1.59
1-Year Change
1.23%
Shares Outstanding
701,932,713
Next Earnings Date
-
What is your sentiment on Biotron Ltd?
or
Market is currently closed. Voting is open during market hours.

Biotron Ltd Company Profile

Employees
0
Market
Australia

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also develops a portfolio of preclinical antiviral drugs. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellBuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyBuyStrong BuyNeutralBuy
SummaryNeutralBuyStrong BuyBuyStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.